Investors / filer profile

Moreadith Randall

Chief Scientific Officer

active in 1 company

Pro
Bought: Pro
Sold: 78
Filings: 1
Companies: 2026-02-02
Last filed

EDGAR · CIK 0001301120 ↗

Track record

How each disclosed position did against the S&P ~6 months later

No positions we can measure against the market yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$0.0000 bought · −$1.00M sold

All filings on record

Every Form 4 transaction we track for this filer


SERSerina Therapeutics, Inc.	Sell $19.7K · 6,500 sh	2026-02-02	—
SERSerina Therapeutics, Inc.	Exercise $390.00 · 6,500 sh	2026-02-02	—
SERSerina Therapeutics, Inc.	Sell $23.2K · 6,500 sh	2026-01-28	—
SERSerina Therapeutics, Inc.	Exercise $390.00 · 6,500 sh	2026-01-28	—
SERSerina Therapeutics, Inc.	Sell $7.4K · 2,500 sh	2026-01-22	—
SERSerina Therapeutics, Inc.	Exercise $150.00 · 2,500 sh	2026-01-22	—
SERSerina Therapeutics, Inc.	Sell $6.0K · 2,000 sh	2026-01-21	—
SERSerina Therapeutics, Inc.	Exercise $120.00 · 2,000 sh	2026-01-21	—
SERSerina Therapeutics, Inc.	Sell $6.1K · 2,000 sh	2026-01-20	—
SERSerina Therapeutics, Inc.	Exercise $120.00 · 2,000 sh	2026-01-20	—

SERSell

2026-02-02 · Serina Therapeutics, Inc.

$19.7K

—

SERExercise

2026-02-02 · Serina Therapeutics, Inc.

$390.00

—

SERSell

2026-01-28 · Serina Therapeutics, Inc.

$23.2K

—

SERExercise

2026-01-28 · Serina Therapeutics, Inc.

$390.00

—

SERSell

2026-01-22 · Serina Therapeutics, Inc.

$7.4K

—

SERExercise

2026-01-22 · Serina Therapeutics, Inc.

$150.00

—

SERSell

2026-01-21 · Serina Therapeutics, Inc.

$6.0K

—

SERExercise

2026-01-21 · Serina Therapeutics, Inc.

$120.00

—

SERSell

2026-01-20 · Serina Therapeutics, Inc.

$6.1K

—

SERExercise

2026-01-20 · Serina Therapeutics, Inc.

$120.00

—

Newest 10 of 78 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.